OpenBilldrug price receipt

NADAC week of 2026-10-14

ABIRTEGA 250 MG TABLET

FDA nonproprietary name: abiraterone acetate

For 30 tablets

Pharmacies pay

$23.22 filed

30 × $0.77414 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$663.29 filed

30 × $22.10961 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

28.6× estimated

These two figures may not measure the same thing

At 28.6×, the Medicare figure is 20 or more times what pharmacies pay. A gap that large means the two figures may not describe the same unit or product, or the price may have changed between their dates; check what each one covers before relying on the multiple.

Part D averages every strength and form sold under “Abiraterone Acetate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$31.70 estimated

$23.22 + $3.48 (15%) + $5.00 fee per fill = $31.70

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ABIRTEGA 250 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as abiraterone acetate, under the trade name “Abirtega”.

FDA gives its dosage form as tablet and its route as oral; oral.

The labeler, the company named on the label, is CivicaScript, LLC.

FDA’s Established Pharmacologic Class for it is Cytochrome P450 17A1 Inhibitor.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 82249-0011-12.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $23.22 for 30 tablets (30 × $0.77414 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The NDC

Other strengths, forms and brands

2 other products in the NADAC file share the FDA nonproprietary name abiraterone acetate with ABIRTEGA 250 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
ABIRATERONE ACETATE 250 MG TAB
generic · tablet / tablet, film coated
$0.77414 per EA filed
eff. 2026-09-23
$22.10961 per EA filed
Part D 2024 average
ABIRATERONE ACETATE 500 MG TAB
generic · tablet, film coated / tablet
$2.59443 per EA filed
eff. 2026-09-23
$22.10961 per EA filed
Part D 2024 average
ABIRTEGA 250 MG TABLET this page
generic · tablet
$0.77414 per EA filed
eff. 2026-09-23
$22.10961 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $663.29 for 30 tablets, at an average of $22.10961 per EA in 2024 (2024-01-01 to 2024-12-31) for “Abiraterone Acetate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 389,368 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for ABIRTEGA 250 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Abiraterone Acetate / Abiraterone Acetate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.